Evidence map›Paper›PMID 27835950›Full record

ArticleBMC pulmonary medicine2016

Targeted high-throughput sequencing of candidate genes for chronic obstructive pulmonary disease.

Hans Matsson, Cilla Söderhäll, Elisabet Einarsdottir, Maxime Lamontagne, Sanna Gudmundsson, Helena Backman, Anne Lindberg, Eva Rönmark, Juha Kere, Don Sin and 4 more

Open access · goldAbstract read
In one paragraph

Article in BMC pulmonary medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.5field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 18 citations in OpenAlex.

  1. Investigating the role of eight SNPs inAnnals of medicine · 2025
    Article
  2. Article
  3. Progesterone activates GPR126 to promote breast cancer development via the Gi pathway.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 8 institutions in 4 countries.

Hans MatssonDepartment of Biosciences and Nutrition, Karolinska Institutet, 7-9, SE-141 83, Huddinge, Sweden. hans.matsson@ki.se.ORCID 0000-0002-8193-4029
Cilla SöderhällDepartment of Biosciences and Nutrition, Karolinska Institutet, 7-9, SE-141 83, Huddinge, Sweden.
Elisabet EinarsdottirDepartment of Biosciences and Nutrition, Karolinska Institutet, 7-9, SE-141 83, Huddinge, Sweden.
Maxime LamontagneInstitut universitaire de cardiologie et de pneumologie de Québec, Québec, Canada.
Sanna GudmundssonDepartment of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
Helena BackmanDepartment of Public Health and Clinical Medicine, Division of Occupational and Environmental Medicine, Umeå University, Umeå, Sweden.
Anne LindbergDepartment of Public Health and Clinical Medicine, Division of Medicine, Umeå University, Umeå, Sweden.
Eva RönmarkDepartment of Public Health and Clinical Medicine, Division of Occupational and Environmental Medicine, Umeå University, Umeå, Sweden.
Juha KereDepartment of Biosciences and Nutrition, Karolinska Institutet, 7-9, SE-141 83, Huddinge, Sweden.
Don SinThe University of British Columbia Center for Heart Lung Innovation, St-Paul's Hospital, Vancouver, Canada.
Dirkje S PostmaCenter Groningen, GRIAC research institute, University of Groningen, Groningen, The Netherlands.
Yohan BosséInstitut universitaire de cardiologie et de pneumologie de Québec, Québec, Canada.
Bo LundbäckKrefting Research Centre, Institute of Medicine, University of Gothenburg, Gothenburg, Sweden.
Joakim KlarDepartment of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
Umeå University · SEInstitut universitaire de cardiologie et de pneumologie de Québec · CAKarolinska Institutet · SEUniversity of Helsinki · FIUppsala University · SEUniversity of British Columbia · CAUniversity of Gothenburg · SEUniversity of Groningen · NL

Funding

CIHR MOP - 123369
6 · The paper itself

Abstract

backgroundReduced lung function in patients with chronic obstructive pulmonary disease (COPD) is likely due to both environmental and genetic factors. We report here a targeted high-throughput DNA sequencing approach to identify new and previously known genetic variants in a set of candidate genes for COPD.

methodsExons in 22 genes implicated in lung development as well as 61 genes and 10 genomic regions previously associated with COPD were sequenced using individual DNA samples from 68 cases with moderate or severe COPD and 66 controls matched for age, gender and smoking. Cases and controls were selected from the Obstructive Lung Disease in Northern Sweden (OLIN) studies.

resultsIn total, 37 genetic variants showed association with COPD (p < 0.05, uncorrected). Several variants previously discovered to be associated with COPD from genetic genome-wide analysis studies were replicated using our sample. Two high-risk variants were followed-up for functional characterization in a large eQTL mapping study of 1,111 human lung specimens. The C allele of a synonymous variant, rs8040868, predicting a p.(S45=) in the gene for cholinergic receptor nicotinic alpha 3 (CHRNA3) was associated with COPD (p = 8.8 x 10

conclusionOur data replicate previous result suggesting CHRNA5 as a candidate gene for COPD and rs8040868 as a risk variant for the development of COPD in the Swedish population.

Indexed as

AgedCase-Control StudiesFemaleGenetic Predisposition to DiseaseGenome-Wide Association StudyHigh-Throughput Nucleotide SequencingHumansLinkage DisequilibriumLungMaleMiddle AgedNerve Tissue ProteinsPolymorphism, Single NucleotidePulmonary Disease, Chronic ObstructiveReceptors, NicotinicSwedenCHRNA5 protein, humanNerve Tissue ProteinsReceptors, NicotinicAssociationCHRNA5COPDeQTLLung developmentSequencing

Identifiers

PMID27835950
PMCPMC5106844
OpenAlexW2557186738

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.